The aim of present study was to evaluate herbal analgesic cream containing Nigella sativa oil as an active ingredient, standardization of Nigella sativa oil and evaluation of irritation/sensitization potential of formulation. Material & Method: For this, HPLC analysis of oil, skin irritation test on rabbits and patch testing on human skin was conducted. HPLC analysis using C-18 column, using an isocratic mobile phase of water: methanol (10:90) at flow rate of 1 ml/inactive ingredient: thymoquinone purified from the oil was found to be 1.42g (28.4 %). Safety assessment of analgesic cream was based on Primary Dermal Irritation Index (PDII) by Draize method. Result: According to Draize standard scoring system of reactions PDII was found 0.04 which comes under the category of non irritant. Patch testing on human volunteers revealed that none of volunteers showed any sign of skin reactions.
Introduction
Nigella sativa, belonging to botanical family; Ranunculaceae, used as medicinal plant. It is native to North Africa, Southern Europe and Asia but widely cultivated in Pakistan and India. The plant reproduces dicotyledonous capsulated fruits containing numerous white trigonal seeds, which turn black on exposure to air; thus commonly known as Black Seeds 1,2 . It is well known as Habbat Albarakah, Alhabahat Alsawda, and Alkamoun Alaswad among Muslim communities. 3 As established historical and religious basis, it is recommended for a broad range of health problems, and is one of the herbal medicines that are being actively investigated and has worldwide recognition 4 .Its oil comprised of 30% by weight of p-cymene, which is the most original composition, and 61.48% of the weight is composed of the volatile oil. Nigella sativa seeds are rich source of essential fatty acids, unsaturated acids, vitamins, minerals, proteins, and carbohydrates 5 .There are also other compounds in seeds, such as phospholipids, carotene, calcium, iron, and potassium. The biological effects of these compounds on the human body are largely positive. They have shown prominent effects in the treatment of many diseases such as hypertension, headache, diabetes, inflammation, eczema, fever, dizziness, influenza, asthma and bronchitis. 6 The pharmacological properties of N.sativa were also reported by in vitro and in vivo studies conducted on human and laboratory animals. These studies showed that N. sativa and its ingredients have a broad range of medicinal effects such as antimicrobial, antidiabetic, antinephrotoxic,antiinflammatory,antio xidant,antihypertensive,antiasthmatic, antiparasitic and anticancer. 7,8,9. Acute and chronic toxicity studies on laboratory animals reported that Nigella sativa seeds, its oil and thymoquinone(the most plentiful and broadly studied active compound) are safe, particularly when given orally. 10, 11, 12 According to a mobility disability caused by osteoarthritis among the elderly people , a lot of side effects of synthetic drugs and multiple medications exist with no certain cure for it; thus the prevalence of musculoskeletal disorders has been reported in older people in Sabzevar City, especially in the knee joint to evaluate the topical impact of Nigella sativa oil and oral acetaminophen on knee osteoarthritis in the elderly residing in a parents 'nursing home in Sabzevar City of Iran. 13, 14 In present work Nigella sativa oil has been used in cream formulation that is locally used for the treatment of muscular pain, inflammatory conditions, to relieve headache, neuralgic, rheumatic and other allied pains (lumbago, sciatica, stiff muscles and joint pains). This herbal analgesic cream is also recommended in conditions like allergies, eruptions, swellings, warts and insect bite etc. It is prepared from indigenous raw material and can be applied safely. It has an advantage over oral administered preparations as it does not cause gastrointestinal disturbances. The aim of present study is to standardize the Nigella sativa oil as it is an active ingredient and to evaluate skin irritation potential of analgesic cream when long term use is expected. Safety assessment of topical formulations is a primary interest; this must be done by means of in vitro and in vivo tests to determine the risk of irritation by the contact with human skin. Material and Method Chemicals and Equipment.All chemicals used in this study were laboratory grade which included liquid paraffin, white petroleum, white wax, sodium borate, N.hexane(analytical grade) purchased from E.Merck Chemical company. HPLC used was Prominence LC-20A Series, Shimadzu, Japan with PDA. Alumina sheets (Kieselgel 60 F254 0.2mm; Merck, Munich Germany) were used for thin layer chromatography (TLC) and silica gel (230-400 mesh) was used for column chromatography. Visualization of the TLC was carried out by iodine vapors and under UV light at 254 and by spraying with Ceric Sulphate reagent solution (with heating). Thymoquinone used as standard purchased from Aldrich. All solutions used were of HPLC grade. Oil Extraction. Nigella sativa seeds were purchased from local market and submitted to botanist with whole plant for identification. The seeds were dried in shade and grinded in an electrical grinder and wrapped in a filter paper and closed with a second filter paper in a manner so as to prevent the escape of the material. The second filter paper is left open at the top placed in the top of thimble to distribute the solvent as it drops on a sample. The wrapped seeds were placed in the Butt extraction tube and assemble the apparatus according to AOAC, 2004 . 15 N-Hexane (1000ml) was taken in round bottom flask before attaching to the tube. The solvent was removed through distillation and the residue was dried over anhydrous sodium sulphate then filtered off. The rest of the solvent was removed under the gentle stream of Nitrogen then weighed the oil content, repeated the drying procedure until a constant weight was obtained.
Standardization of oil
Preparation of standard.30 mg of standard thymoquinone was taken in 10 ml volumetric flask and dissolved in methanol. The solution was made up to the mark with methanol to give a concentration of 3 mg/ml of thymoquinone. Preparation of sample.10 ml of methanol was added to 5 g of oil extracted from Nigella sativa seeds in a 25 ml flask. It was sonicated for 20 minutes upper methanolic layers was separated and concentrated over vacuum on rotary evaporator. Concentrated viscous liquid was loaded on silica column and eluted with petroleum ether. The fastest moving yellow band was collected in vials and compared on TLC with standard thymoquinone using 10 % chloroform in petroleum ether. It was found to be comparable with standard thymoquinone with an Rf value of 0.35. The vials were combined and evaporated to give 1.836 g of impure thymoquinone. Out of this 30 mg of sample was taken in 10 ml volumetric flask and dissolved in methanol. The solution was made up to the mark with methanol. HPLC analysis .The sample and standard were subjected to HPLC analysis using C-18 column, using an isocratic mobile phase of water: methanol (10:90) at flow rate of 1 ml/min. 16 The detection was made at 254 nm. The peak for extracted thymoquinone matched with that of standard at RT of 1.93 min. The amount was calculated by comparing the area of peak of the standard with that of sample. Fig 1 & 2 . Preparation of Formulation O/W formulation was prepared by adding oily phase to the liquid phase with continuous stirring. In oil phase, the emulsifier (stearic acid) and oil soluble components (cetyl alcohol, Nigella sativa oil) were dissolved and heated up to 70+5C(Part A).At the same time the aqueous phase containing water soluble components like methyl paraban, propyl paraban,propylene glycol (Part B) was heated up to 70+5.After heating, the oily phase was added to aqueous phase with continuous stirring at 2000 rpm by the mechanical mixer for about 20 minutes. Then speed of mixer was reduced to 1000 rpm for homogenization until the emulsion cooled to room temperature. The formulation of cream is given in table 1. 
Results and Discussion
Herbal medicines are being utilized from time immemorial as the major source of treating various ailments and diseases however the major objection on herbal medicines is the lack of scientific data for their quality control. Therefore as pointed out by WHO, guidelines for the production and quality assurance of herbal products needs to be standardize to ensure quality and optimum levels of active principles for their bio-potency. One of the basic requirements is to standardize the raw material for active ingredient. Therefore the oil extracted from Nigella sativa seeds used as active ingredient in this formulation was standardized for its thymoquinone content by the method of Ghosheh,1999 i.e. first by extraction from oil and then by using column chromatography followed by HPLC. The quantity of thymoquinone purified from the oil used in the formulation by column chromatography followed by HPLC was found to be 1.42 g (28.4 %).as showed in fig 1&2. This percentage is close to reported percentage of thymoquinone (30-48%) as various studies showed that thymoquinone also known as 2-isopropy l-5methyl-1,4-benzoquinone is mainly responsible for the biological activity of Nigella sativa seeds which is pre-dominantly. 20, 21, 22 All physical parameters of cream were evaluated and the result was presented in table 4 . Nigella sativa oil is stable formulation and safe for long term topical use for various muscular problems.
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